Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dudley Robinson

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Expert Opinion on Investigational Drugs|October 6, 2004
The emerging role of solifenacin in the treatment of overactive bladderDudley Robinson, Linda Cardozo
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacotherapy of overactive bladder syndromeDudley Robinson, Linda Cardozo
Current Urology Reports|November 12, 2002
Overactive bladder in the female patient: the role of estrogensDudley Robinson, Linda Cardozo
Urology|December 21, 2002
Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladderLinda Cardozo, Dudley Robinson
Women'S Health (London, England)|March 8, 2014
Urinary incontinence in the young woman: treatment plans and options availableDudley Robinson, Linda Cardozowan
F1000Prime Reports|October 25, 2014
Prevention and management of pelvic organ prolapseIlias Giarenis, Dudley Robinson
Expert Opinion on Drug Safety|August 29, 2020
The cognitive safety of antimuscarinics in the treatment of overactive bladderGeorge Araklitis, Dudley Robinson
Expert Opinion on Pharmacotherapy|February 1, 2025
Up-and-coming pharmacotherapeutic options for treating patients with refractory overactive bladderRayan Mohamed-Ahmed, Dudley Robinson
Urology|October 11, 2003
The role of estrogens in female lower urinary tract dysfunctionDudley Robinson, Linda D Cardozo
Expert Opinion on Pharmacotherapy|December 4, 2009
Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladderDavid R Staskin, Dudley Robinson
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Expert Opinion on Investigational Drugs|October 6, 2004
The emerging role of solifenacin in the treatment of overactive bladderDudley Robinson, Linda Cardozo
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacotherapy of overactive bladder syndromeDudley Robinson, Linda Cardozo
Current Urology Reports|November 12, 2002
Overactive bladder in the female patient: the role of estrogensDudley Robinson, Linda Cardozo
Urology|December 21, 2002
Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladderLinda Cardozo, Dudley Robinson
Women'S Health (London, England)|March 8, 2014
Urinary incontinence in the young woman: treatment plans and options availableDudley Robinson, Linda Cardozowan
F1000Prime Reports|October 25, 2014
Prevention and management of pelvic organ prolapseIlias Giarenis, Dudley Robinson
Expert Opinion on Drug Safety|August 29, 2020
The cognitive safety of antimuscarinics in the treatment of overactive bladderGeorge Araklitis, Dudley Robinson
Expert Opinion on Pharmacotherapy|February 1, 2025
Up-and-coming pharmacotherapeutic options for treating patients with refractory overactive bladderRayan Mohamed-Ahmed, Dudley Robinson
Urology|October 11, 2003
The role of estrogens in female lower urinary tract dysfunctionDudley Robinson, Linda D Cardozo
Expert Opinion on Pharmacotherapy|December 4, 2009
Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladderDavid R Staskin, Dudley Robinson
Pageof 17